ArticleTranslational cancer research2025
Molecular characterization and prognostic modeling of liquid-liquid phase separation-related genes in osteosarcoma based on single-cell sequencing and weighted gene co-expression network analysis.
Article in Translational cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The CCT6A paradigm: biomarker potential and therapeutic challenges in oncology and beyond.Molecular biology reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In recent years, liquid-liquid phase separation (LLPS) has garnered increasing attention in the field of oncology. However, its role in osteosarcoma remains largely unexplored. We aimed to construct a prognostic risk model associated with LLPS and to investigate the impact of LLPS-related genes on osteosarcoma briefly. Methods: Based on the single-cell dataset GSE162454, LLPS gene expression scores were calculated to stratify osteosarcoma samples into high and low LLPS expression cohorts, followed by differential analysis between the two groups. Using bulk transcriptomic data from GSE21257, LLPS scores were computed for each sample, and weighted gene co-expression network analysis (WGCNA) was performed to identify modules most strongly related to LLPS. Cox and least absolute shrinkage and selection operator (LASSO) regression analyses were performed on the genes that overlap between the two datasets to identify LLPS-related prognostic genes. A prognostic model was subsequently constructed, a nomogram was developed for clinical application, and its independent prognostic value was evaluated. Additionally, selected results were validated experimentally. Results: The LLPS-related prognostic model comprising seven genes, Conclusions: This study offers a novel framework for risk stratification in osteosarcoma, identifies seven novel LLPS-associated prognostic biomarkers, and presents valuable perspectives on the pathogenesis and potential therapeutic targets of osteosarcoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.